Who
Rifat Pamukcu
Director
Company insider
Files Form 4 as: Director, Aprea Therapeutics.
In numbers
- Trades disclosed
- 16
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 28 Jul 2022
- Last trade
- 16 Jun 2026
- Last filed
- 17 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Jun 2026filed 17 Jun 2026 | APRE Aprea TherapeuticsBiotechnology | SEC FORM 4 Code A | —3,135 at $0.00 | filing |
| 16 Jun 2026filed 17 Jun 2026 | APRE Aprea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,555 at $0.00 | filing |
| 16 Jun 2026filed 17 Jun 2026 | APRE Aprea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,555 at $0.00 | filing |
| 16 Jun 2026filed 17 Jun 2026 | APRE Aprea TherapeuticsBiotechnology | SEC FORM 4 Code A | —3,135 at $0.00 | filing |
| 5 Jun 2025filed 9 Jun 2025 | APRE Aprea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,185 at $0.00 | filing |
| 5 Jun 2025filed 9 Jun 2025 | APRE Aprea TherapeuticsBiotechnology | SEC FORM 4 Code A | —1,045 at $0.00 | filing |
| 20 Jun 2024filed 21 Jun 2024 | APRE Aprea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,185 at $0.00 | filing |
| 20 Jun 2024filed 21 Jun 2024 | APRE Aprea TherapeuticsBiotechnology | SEC FORM 4 Code A | —1,045 at $0.00 | filing |
| 23 Aug 2023filed 24 Aug 2023 | APRE Aprea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,000 at $0.00 | filing |
| 23 Aug 2023filed 24 Aug 2023 | APRE Aprea TherapeuticsBiotechnology | SEC FORM 4 Code A | —500 at $0.00 | filing |
| 23 Aug 2022filed 24 Aug 2023 | APRE Aprea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —4,928 at $0.00 | filing |
| 23 Aug 2022filed 24 Aug 2023 | APRE Aprea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —27,187 at $0.00 | filing |
| 23 Aug 2022filed 24 Aug 2023 | APRE Aprea TherapeuticsBiotechnology | SEC FORM 4 Code C | —49,280 at $0.00 | filing |
| 23 Aug 2022filed 24 Aug 2023 | APRE Aprea TherapeuticsBiotechnology | SEC FORM 4 Code C | —271,870 at $0.00 | filing |
| 28 Jul 2022filed 1 Aug 2022 | APRE Aprea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,575 at $0.00 | filing |
| 28 Jul 2022filed 1 Aug 2022 | APRE Aprea TherapeuticsBiotechnology | SEC FORM 4 Code A | —5,995 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.